Clinical Trial Update: Irofulven in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for irofulven in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irofulven (irofulven)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED